2016
DOI: 10.1016/j.ejps.2016.07.004
|View full text |Cite
|
Sign up to set email alerts
|

Formulation and in vitro evaluation of polymeric enteric nanoparticles as dermal carriers with pH-dependent targeting potential

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
14
0
1

Year Published

2019
2019
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 47 publications
(15 citation statements)
references
References 31 publications
0
14
0
1
Order By: Relevance
“…Nanoparticle approaches like polymeric nanoparticles have been found promising to overcome traditional problems as low solubility, higher stability, sharper size distribution, sustained and controlled release profiles, higher encapsulation efficiency for weakly water soluble agents and can be effective in enhancing bioavailability with better targeting efficiency [ 15 , 16 ]. Chitosan found to carry a variety of hydrophilic and hydrophobic drugs and poloxamer 407 is a nonionic US FDA approved stabilizer used in various formulations [ 17 , 18 , 19 ]. However, the surface properties of polymeric nanoparticles are altered by surface modification and/or to improve the pharmacokinetics of these colloidal carriers here chitosan is used as a polymer [ 16 , 20 ].…”
Section: Introductionmentioning
confidence: 99%
“…Nanoparticle approaches like polymeric nanoparticles have been found promising to overcome traditional problems as low solubility, higher stability, sharper size distribution, sustained and controlled release profiles, higher encapsulation efficiency for weakly water soluble agents and can be effective in enhancing bioavailability with better targeting efficiency [ 15 , 16 ]. Chitosan found to carry a variety of hydrophilic and hydrophobic drugs and poloxamer 407 is a nonionic US FDA approved stabilizer used in various formulations [ 17 , 18 , 19 ]. However, the surface properties of polymeric nanoparticles are altered by surface modification and/or to improve the pharmacokinetics of these colloidal carriers here chitosan is used as a polymer [ 16 , 20 ].…”
Section: Introductionmentioning
confidence: 99%
“…Franz chambers, a popular method for measuring the diffusion rates, were used to determine substance permeation released from the carrier through a membrane imitating artificial skin in a PBS environment [29]. The Franz diffusion cell test enabled the in vitro evaluation of polymeric enteric nanoparticles as the dermal carriers with pH-dependent targeting potential [30], or the assessment of the reverse micelle of lipophile-functionalized PEG dendrimer hybrids for applications in carrier-mediated transdermal drug delivery [31]. Therefore, Franz diffusion cells were also selected to evaluate the permeation through the membrane of the studied micellar carriers and conjugates.…”
Section: Permeation Testsmentioning
confidence: 99%
“…Polymethylmethacrylate (PMMA) polymers (Eudragit) are employed as drug delivery systems targeting different specific organs such as stomach, duodenum and colon, epithelial cells and their membranes, skin surface, and hair follicles …”
Section: Introductionmentioning
confidence: 99%